Effects of comorbidity on health-related quality-of-life scores: An analysis of clinical trial data

Clinical Therapeutics

Volumn 21, Issue 2, 1999, Pages 383-403

  Xuan, Jianwei ^a,d   Kirchdoerfer, Leonard J ^b   Boyer, J Gregory ^b   Norwood, G Joseph ^c  

^a SmithKline Beecham   (United States)

^b GLAXOSMITHKLINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d Pharmacoeconomic/Outcomes Research   (United States)

Author keywords

Clinical trials; Comorbidity effect; Health related quality of life measures

Indexed keywords

ADULT; ARTHRITIS; ARTICLE; ASTHMA; BACKACHE; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEPRESSION; DOUBLE BLIND PROCEDURE; FEMALE; HEARTBURN; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIGRAINE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT OUTCOME; ULCER; WELLBEING;

EID: 0032950297     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(00)88295-8     Document Type: Article

References (34)

1. 1. Barnett D. Assessment of quality of life. Am J Cardiol. 1991;67:41C-44C.
2. 2. Mayou R. QOL in cardiovascular disease. Psychother Psychosom. 1990;564:99-109.
3. 3. Patrick DL, Deyo R. Generic and disease-specific measures in assessing health status and quality of life. Med Care. 1989;27(Suppl):217-232.
4. 4. Ware JE. Generic versus specific health status measures. Med Outcomes Trust Bull. 1994;2:2-4.
5. 5. Ware JE. Conceptualizing disease impact and treatment outcomes. Cancer. 1984;53(Suppl 10):2316-2326.
6. 6. Feinstein AR. The pre-therapeutic classification of co-morbidity in chronic disease. J Chronic Dis. 1970;23:455-468.
7. 7. Maser JD, Cloninger CR. Comorbidity of Mood and Anxiety Disorders. Washington, DC: American Psychiatric Press, Inc.; 1990.
8. 8. Cole DA, Carpentieri S. Social status and the comorbidity of child depression and conduct disorder. J Consult Clin Psychol. 1990;58:748-757.
9. 9. Robins PM. A comparison of behavioral and attentional functioning in children diagnosed as hyperactive or learning disabled. J Abnorm Child Psychol. 1992;20:65-82.
10. 10. Freeman EW. Gonadotropin-releasing hormone agonist in treatment of premenstrual symptoms with and without comorbidity of depression: A pilot study. J Clin Psychiatry. 1993;54:192-195.
11. 11. Greenfield S, Apolone G, McNeil BJ, Cleary PD. The importance of co-existent disease in the occurrence of postoperation complications and one-year recovery in patients undergoing total hip replacement -comorbidity and outcomes after hip-replacement. Med Care. 1993;31:141-154.
12. 12. Sullivan M, Katon WJ, Russo J, et al. Socialization, comorbidity, and the quality of life: Measuring the effect of depression upon chronic medical illness. Psychiatr Med. 1992;10:61-76.
13. 13. Massion AO, Warshaw MG, Keller MB, Quality of life and psychiatric morbidity in panic disorder and generalized anxiety disorder. Am J Psychiatry. 1993;150:600-607.
14. 14. Andreoli A, Keller SE, Rabacns M, et al. Immunity, major depression, and panic disorder comorbidity. Biol Psychiatry. 1992;31;896-908.
15. 15. Nicolucci A, Cubasso D, Labbrozzi D, et al. Effect of coexistent diseases on survival of patients undergoing dialysis. ASAIO J. 1992;38:M291-M295.
16. 16. Harris LE. Clinical correlates of functional status in patients with chronic renal insufficiency. Am J Kidney Dis. 1993;21:161-166.
17. 17. Philips R. Patient characteristics in support: Sociodemographics, admission diagnosis, co-morbidities and acute physiology score. J Clin Epidemiol. 1990;43(Suppl):29S-31S.
18. 18. Mangione CM, Seddon JM, Cook GF, et al. Correlates of cognitive function scores in elderly outpatients. J Am Geriatr Soc. 1993;41:491-497.
19. 19. Mangione CM, Marcantonio ER, Goldman L, et al. Influence of age on measurement of health status in patients undergoing elective surgery. J Am Geriatr Soc. 1993;41;377-383.
20. 20. Strawbridge WJ, Kaplan GA, Camacho T, Cohen RD. The dynamics of disability and functional change in an elderly cohort: Results from the Alameda County study. J Am Geriatr Soc. 1992;40:799-806.
21. 21. Fryback DG, Laurence WF. Indexes for post hoc adjustment of health outcomes comparisons for age and comorbidities. In: Program and Abstracts of the 15th Annual Meeting of the Society for Medical Decision Making; October 24-27, 1993; Durham, North Carolina.
22. 22. Parkerson GR, Connis RT, Broadhead WG, et al. Disease-specific versus generic measurement of health-related quality of life in insulin-dependent diabetic patients. Med Care. 1993;31:629-639.
23. 23. Data on file. A randomized, double-blind placebo controlled evaluation for the treatment of episodic heartburn. Research Triangle Park, NC: Glaxo Research Institute; 1994.
24. 24 Data on file, A randomized, double-blind, three parallel-group, comparative trial in adolescent and adult patients with moderate asthma. Research Triangle Park, NC: Glaxo Research Institute; 1994.
25. 25. Data on file. A randomized, double-blind placebo controlled evaluation for the acute treatment of duodenal ulcer and ulcer relapse. Research Triangle Park, NC: Glaxo Research Institute; 1994.
26. 26. Stewart AL, Greenfield S, Hays RD, et al. Functional status and well-being of patients with chronic conditions - results from the Medical Outcomes Study. JAMA. 1989;262:907-913.
27. 27. Ware JE. SF-36 Health Survey - Manual and Interpretation Guide 1993. Boston: The Health Institute, New England Medical Center; 1993.
28. 28. Boyer G, Aaronson D, Meltzer H, et al. Enhancement of a general quality of life scale: Validation of a sleep scale. Presented at: Annual Meeting of the American Academy of Allergy, Asthma and Immunology; March 6-11, 1992; Orlando, Florida. Abstract.
29. 29. Hyland ME, Finnis S, Irvine SH. A scale for assessing quality of life in adult asthma sufferers. J Psychosom Res. 1991;35:99-110.
30. 30. Testa MA, Anderson RB, Nackley JF, Hollenberg NK. Quality of life and antihypertensive therapy in men: A comparison of captopril with enalapril. NEJM. 1993; 328:907-913.
31. 31. Croog SH, Levine S, Testa MA, et al. The effects of antihypertensive therapy on the quality of life (QOL). NEJM. 1986;314;1657-1664.
32. 32. SAS/STAT User's Guide-Release 6.03. Cary, NC: SAS Institute Inc.; 1993.
33. 33. Testa MA, Lenderking WR, Interpreting pharmacoeconomic and quality-of-life clinical trial data for use in therapeutics. Pharmacoeconomics. 1992;2;107-117.
34. 34. Hulley SB, Cummings SR. Designing Clinical Research. Baltimore: Williams & Wilkins; 1988:215-216.